Human Trial Results Show Excellent Safety Data, From Geovax's DNA/MVA AIDS Vaccines

Fri, 09 Feb 2007 03:00 PM EST

... GeoVax Labs, Inc. (OTC BB: GOVX), an Atlanta-based biotechnology company, today reported successful early results from two ongoing AIDS prevention Phase I human vaccine trials. Results from the first low dose trial indicate a good safety profile as well as positive immune responses in human volunteers receiving 1/10th dose of GeoVax's AIDS vaccine. [click link for full article] ...